Random transposon mutagenesis is a powerful genetic tool to answer fundamental biological questions 11 in an unbiased approach. Here, we introduce an improved mariner-based transposon system with 12 higher stability, and with versatile applications. We take advantage of the lower frequency of 13 unintended recombination during vector construction and propagation in a low copy number system in 14 E. coli to improve construct integrity. We generated a variety of transposons allowing for gene 15 disruption or artificial overexpression each in combination with one of four different antibiotic 16 resistance markers. In addition, we provide transposons that will report gene/protein expression due 17 to transcriptional or translational coupling. We believe that the TnFLX system will help enhance 18 flexibility of future transposon modification and application in Bacillus and other organisms. 19 20 Tn917-based systems (17)(18)(19). Later, our group constructed second generation derivatives of the mariner 58 system adding additional antibiotic cassettes and transposons for random transcriptional reporter 59 insertions of the β-galactosidase gene lacZ and random artificial expression insertions with an outward 60 facing IPTG-inducible promoter (20). 61
The optimization of transposase encoding vectors in terms of stability during cloning and propagation is 31 crucial for the reliable application of this system in any host organism. With an increased number of 32 antibiotic resistance markers and the possibility to detect translational activity, the TnFLX transposon 33 system will significantly help the implication of forward genetic methods in the field of cellular biology. 34
INTRODUCTION 37
Transposon mutagenesis is a powerful method in molecular genetics, as it combines random 38 insertional mutagenesis with the generation of linked antibiotic markers and rapid insertion site 39 identification. Typically, an antibiotic resistance cassette is cloned between two inverted terminal repeat 40 elements (ITR elements) that define the transposon. Next, the transposase enzyme is provided as purified 41 protein in vitro or expressed from a gene in vivo to recognize and mobilize the transposon to another 42 random genetic location (1-3). Different transposon systems have different transposition frequencies, 43 different insertion biases, and different mechanisms for providing the transposase. Moreover, the 44 functionality of transposons can be extended by cloning additional genetic material between the IS 45 elements. For instance, transposon derivatives have been generated that insert not only the antibiotic 46 resistance cassette but other genes and promoters for the generation of randomly inserted reporter 47 fusions and artificial expression systems (4-8). 48
Bacillus subtilis is a model genetic organism and a number of transposon systems have been 49 developed to aid genetic analyses. The earliest transposon system developed for B. subtilis was Tn917 50 which generated random insertions but exhibited a strong bias toward insertions near the chromosome's 51 terminus (9-11). The next system used transposon Tn10 that improved insertion diversity and provided 52 an easier method for insertion site identification but was still prone to insertions at particular locations or 53 "hotspots" (12-16). Later the first generation of systems using transposon mariner was developed that 54 inserted at two-base pair "TA" sequences in the chromosome thus increasing the potential number of 55 insertion sites in low G+C content organisms (2). Sequencing of transposon pools (TnSeq) indicates that 56 mariner-based transposition is highly random and seems to alleviate "hotspotting" issues of the Tn10 and 57
Here we report the construction of a third-generation of mariner-based transposons that affords 68 increased stability in E. coli through the use of a low-copy number delivery plasmid. Moreover, we 69 regenerate all of the second-generation plasmids using the new platform, add an additional antibiotic 70 resistance cassette conferring resistance to tetracycline, and create a new transposon derivative for the 71 generation of random C-terminal translational fusions to green fluorescent protein (GFP). 72 73 74 75
RESULTS AND DISCUSSION 76
Redesign of the transposon delivery system. Himar-based systems for random transposon mutagenesis 77 were already described for B. subtilis ((21)(20)). Unfortunately, while working with the existing TnKRM 78 series of himar based transposon system we realized a high frequency of genetic reorganization in the 79 delivery plasmid during cloning and proliferation in an E. coli DH5α host. Purification of plasmids from 80 separate clonal isolates of E. coli indicated a heterogeneous pattern of fragments, none of which 81 resembled the digestion pattern predicted for the intact plasmid ( Fig. 1A) . We attribute this inconsistency 82 of the genetic arrangement to recombination events performed by the plasmid-encoded transposase. 83
Transposase expression might be high in E. coli as the himar gene was under the conserved and 84 constitutive σ 70 /σ A promoter sequence of E. coli/B. subtilis. Moreover, the replication origin of the 85 transposon delivery plasmid was derived from high-copy number pUC plasmids (22), further amplifying 86 the potential for himar expression. We infer that expression of the himar transposase likely contributes 87 to high-frequency transposition, plasmid rearrangements, and a loss of plasmid sequence integrity 88 including the loss of the transposon itself. 89
In an effort to increase plasmid fidelity, we chose to design a new transposon delivery system, based on 90 a low copy number plasmid and a modified promoter for the transposase encoding gene. As the vector 91 backbone, we chose the pGB2 (23) plasmid (kind gift of T. Bernhard, Harvard University). It consists of a 92 low activity origin of replication (oriEc) that will only allow for a few replication cycles during the generation 93 time of a E. coli cell and a spectinomycin resistance cassette (specEc R ) for plasmid maintenance during 94 passage in a E. coli host. An erythromycin resistance cassette (erm R ) was integrated into pGB2 to allow for 95 selection of plasmid uptake in the B. subtilis host. Next, we integrated the himar expression construct of 96 the plasmid pMarB (21), so transposase expression was under the control of a B. subtlis promoter 97 recognized by the stress response sigma factor σ B , further reducing the likelihood of expression in E. coli. 98
To complete our transposon delivery system (pFK7) (Fig 2) , we integrated a temperature sensitive origin 99 of replication specific for B. subtilis (oriBs Ts ) to allow replication in the host at permissive temperatures 100 (<30°C) (24-27). In addition, we included a single intergenic SmaI restriction site for blunt end 101 linearization, allowing for the integration of various transposable elements into this system by isothermal 102 assembly (28). 103
Construction of TnFLX and reconstruction of the TnKRM series of transposons 104
The first generation of mariner-based transposon system included a mariner transposon containing a 105 single antibiotic resistance cassette conferring kanamycin resistance (TnYLB-1) (2). The second generation 106 of modified mariner transposons, TnKRM, introduced transposons that had the kanamycin resistance 107 cassette as well as two other transposons separately carrying resistance to spectinomycin and 108 chloramphenicol respectively (20). Here we constructed transposons separately carrying genes conferring 109 resistance to kanamycin (kan R ), spectinomycin (specBs R ), chloramphenicol (cat R ) and a fourth cassette 110 conferring resistance to tetracycline (tet R ) (Fig. 2 ). In addition, all antibiotic resistance cassettes were 111 flanked by a common short nucleotide sequence, which will allow for transposon insertion-site 112 identification with the same pair of oligonucleotides (with the exception of the TnFLXPhyi series that 113 requires a distinct set of oligonucleotides) (see table 1). 114
As proof-of-concept each transposon was introduced into B. subtilis NCIB3610 cells (29). Cells 115 were propagated in LB medium at room temperature overnight, diluted and regrown in LB medium at the 116 non-permissive temperature of 42° C for 6 hours, dilution plated on LB-agar plates containing the 117 transposon specific antibiotic and incubated overnight at 42° C. Whereas wild type colonies have a dull, 118 rough architecture, mutant colonies were isolated that exhibited a shiny, smooth colony morphology 119 indicative of a biofilm defect (30). Inverse PCR was used to identify the location of each transposon 120 insertion and each strain was found to be disrupted in a gene previously reported to be involved in biofilm 121 formation ( Table 2) . One mutant was isolated with a hyper rough phenotype indicative of EPS 122 overproduction and one mutant was isolated with a mucoid colony morphology indicative of poly-γ-123 glutamate overproduction. Again, each mutant was disrupted for a gene previously reported to confer 124 the associated phenotype (Table 2 ). We conclude that the TnFLX series of transposons randomly insert in 125 the chromosome and create loss-of-function mutations. 126
In addition to gene disruption, the artificial expression of a gene in a non-physiological context 127 can reveal valuable information about the function of a gene product. To allow for this kind of artificial 128 control over gene expression, a transposon TnHyJump was created with an antibiotic resistance cassette 129 and a strong Physpank promoter (31) cloned facing outward from one arm of the transposon. The lacI gene 130 encoding the Physpank repressor protein LacI could be separately integrated at an ectopic location in the 131 chromosome to provide IPTG-inducible control. Here, we created the TnFLXPhyi series of transposons in 132 which an antibiotic resistance cassette was also combined with the outward facing Physpank promotor (kind 133 gift from D. Rudner, Harvard University). In the TnFLXPhyi case, however, the lacI gene was also encoded between the insertion elements such that IPTG-inducible control was inherent with, and linked to, each 135 insertion ( Fig. 2) . 136
The TnFLXPhyi system was validated by performing a transposon mutagenesis in B. subtilis PY79 cells. 137
Overexpression blue/white screens using the previous generation TnHyJump system indicated that 138 insertions upstream of cryptic β-galactosidase genes could confer a blue color (20). Therefore, after 139 mutagenesis, cells were spread on plates containing the transposon-specific antibiotic, the inducer IPTG 140 and the indicator X-Gal, and incubated overnight at the non-permissive temperature. Subsequently, plates 141 were examined for blue colonies, indicating the enzymatic cleavage of X-gal. Blue colonies were observed 142 at a low frequency of approximately one per thousand ( Fig 3A) . We isolated 12 blue colonies (3 for each 143 different transposon used) (see table 3 ) and identified the transposon insertion site by IPCR (Table 1) . 144
Insertions of the transposon in 9 out of 12 mutants were found to be within the large yes operon and 145 oriented such that the Physpank promoter could drive artificial expression of the yesZ gene encoding a cryptic 146 β-galactosidase (table 3) . For one strain the transposon was integrated such that the Physpank promoter 147 was inserted in, and co-oriented with, the coding sequence for ganQ. Analysis of the downstream region 148 of the ganQ encoding operon showed the presence of the gene encoding for another β-galactosidase, 149
GanA (formerly LacA) (32). Finally, two transposons were found to be inserted within the ganR gene, and 150 unlike the other 10 insertions, the blue color was IPTG-independent ( FadR, and the dps gene, encoding the iron storage protein Dps (Fig. 4B ). Either these proteins normally 193 localize diffusely in the cytoplasm or insertion of the transposon and premature truncation of the coding 194 sequence in favor of the GFP fusion altered localization. At most, we can infer that the expression of these 195 genes occurs during vegetative growth uniformly in the population. In contrast, two TnFLXgfp fusions in 196 the iolG gene, encoding the inositol 2-dehydrogenase IolG, and the spoVG gene, encoding the RNA-197 binding regulatory protein SpoVG, gave rise to diffuse localization in the cytoplasm but only in a subset of 198 cells in the population. Again, while lack of a subcellular localization pattern cannot be concluded with 199 confidence based on loss-of-function insertion, the expression of the iolG and spoVG genes appears to be 200 heterogeneous. We conclude that TnFLXgfp is useful for generating translational reporters that can also 201 reveal subpopulation level gene expression in some cases. 202
Four TnFLXgfp insertion mutant strains showed fluorescence that was enriched at the cell 203 periphery (Fig. 4C) The last four TnFLXgfp strains indicated alternate localization patterns (Fig. 4D) . For example, one 215 mutant strain with an insertion into the coding region of the protease subunit ClpC, showed diffuse 216 cytoplasmic localization with a sub fraction that accumulated as more intense puncta in the cytoplasm. 217
The diffuse and punctate localization pattern of ClpC is consistent with some subcellular localization 218 reports for this protein ((40)(41)). Two different insertions were found in the coding region of the 219 chemotaxis protein CheV, and each insertion gave rise to intense cytoplasmic foci of variable size that 220 sometimes appeared to be membrane-associated. Again, reports in B. subtilis and Helicobacter pylori 221 support a punctate localization for CheV (42) (43). Finally, a strain harboring an insertion in the coding 222 sequence of the alanine dehydrogenase SpoVN, produced filament-like structures that seemed to be 223 localized near the cell periphery. Filamentous localization is an unusual pattern in bacteria, and while the 224 localization of SpoVN in particular has not been directly investigated in B. subtilis, we note that other 225 metabolic enzymes, e. g. the CTP synthase in the α-proteobacterium C. crescentus, has been reported to 226 form filamentous structures ((44)(45)). 227
Here we generate a transposon delivery vehicle with increased stability in E. coli and that is 228 amenable to easy modification. Moreover, we reproduce the previous-generation series of modified 229 mariner-based transposons and develop a new reporter tool in the form a TnFLXgfp for making random 230 fluorescent translational fusions in vivo. All plasmids will be donated to the Bacillus Genetic Stock Center 231 (BGSC) for community acquisition. We note that while the new generation of plasmids are substantially 232 more stable than the previous, propagation of transposons is inherently destabilizing due to spontaneous 233 transposition, and thus we recommend minimal propagation and careful handling as a precaution. 
MATERIALS AND METHODS 241

Strain construction 242
For the construction of the transposon delivery vectors, all plasmids were amplified in E. coli DH5α (see 243 table 7 for all strains used in this study). To allow for transformation of B. subtilis, E. coli TG1 cells were 244 transformed with the plasmids to generate concatenation. If not stated differently, all B. subtilis strains 245 derived from the naturally competent modified undomesticated strain DK1042. Cells were incubated in 246 lysogeny broth medium (5% (w/v) Yeast extract, 10% (w/v) tryptone, 0.09 M NaCl) or on plates containing 247 this medium fortified with agar (1.5% (w/v)). Antibiotics were supplemented when appropriate at 248 following concentrations: 100 µg/ml spectinomycin, 5 µg/ml kanamycin, 10 µg/ml tetracycline, 5 µg/ml 249 chloramphenicol, mls (1 µg/ml erythromycin, 25 µg/ml lincomycin. For Physpank promoter dependent gene 250 expression, 1 mM Isopropyl-β-d-1-thiogalactopyranoside (IPTG) was added to the medium. For 251 colorimetric assays, using β-galactosidase activity as a readout, 0.5 mM X-Gal was supplemented. 252
Plasmid construction 253
The plow copy-number plasmid pGB2 was linearized by SmaI treatment and complemented with an 254 erythromycin resistance cassette (erm R ) and a temperature sensitive origin of replication (oriBsTs), 255 amplified from pMarB(2) using the oligonucleotides 5211 and 4991 by isothermal assembly (see table 6  256 for oligodesoxyribonucleotides used in this study), giving rise to pFK175. In a next step pFK175 was 257 linearized with SmaI and the mariner-Himar1 transposase coding region controlled by a σ B dependent 258 promoter, amplified from pMarB with the oligonucleotides 5212 and 5214, was integrated by isothermal 259 assembly, creating pFK7. This plasmid was used as universal acceptor of all transposons described in this 260 study. 261
The different transposons were constructed by PCR and integrated, as one or two DNA fragments 262 respectively, into the SmaI linearized plasmid pFK7 by isothermal assembly. 263
Transposons were constructed as follows: 264
For all transposons the antibiotic resistance cassettes were amplified form from pDG1515 (46) 265 (tetracycline resistance cassette (tet R )), pAH54 (47) (spectinomycin resistane cassette (spec R )), pAC225 266 (48)(chloramphenicol resistance cassette (cat R )), and pDG780 (46) (kanamycin resistance casstette (kan R )). 267
For the TnFLX series, the antibiotic resistance cassettes were amplified and extended with the inverted 268 terminal repeats (ITRs) using the oligonucleotides 6142 and 6143. To allow for isothermal assembly, 269 sequences overlapping with the SmaI linearized pFK7 plasmid were introduced by PCR with the 270 oligonucleotides 5759 and 5760. 271
The TnFlexLacZ transposon series was assembled in a sequential manner. To Allow transcriptional 272 coupling, first, the lacZ gene as well as a ribosomal binding site were amplified from pEP22 (49) To generate a transposon allowing for the translational fusion of proteins with monomeric super folder 291 green fluorescent protein (msfGFP), the coding sequence for msfgfp was analyzed, modified for optimal 292 tRNA utilization according to the IDT codon optimization tool (www.idtdna.com) and synthesized by 293 integrated DNA technologies (IDT). The obtained fragment, which already contained a single proximal ITR 294 sequence, was equipped with a second, distal, ITR sequence by amplification with the oligos 6925 and 295 6977. To allow for integration into the acceptor plasmid, flanking homologies to pFK7 were introduced by 296 PRC with 5759 and 5760, following an ITA reaction with SmaI linearized pFK7, creating pFK161. Antibiotic 297 resistance cassettes were introduced into pFK161 by amplification of the coding region with the 298 oligonucleotides 6978 and 5760 and a subsequent ITR reaction with SmaI linearized pFK161.
Transposon mutagenesis 300
The transposon harboring plasmids were introduced into the B. subtilis acceptor strain via 301 transformation (50), selecting for mls resistance and incubated at 30° C for 48 hours. Subsequently, cells 302 were incubated for 16 hours at room temperature in LB-medium containing mls. The cell suspension 303 was diluted 1:100 in LB medium containing the transposon specific antibiotic. The culture was grown for 304 6 hours at 42° C to cure the cells of the plasmid. To obtain individual colonies, the cell suspension was 305 serially diluted and spread on LB plates, containing the appropriate antibiotic, and incubated overnight 306 at 42° C. 307 308
Transposon insertion site identification by inverse PCR (IPCR) 309
Cells were grown in LB medium at 37° for 6 hours. DNA was isolated and digested with the restriction 310 endonuclease Sau3AI. Ligation with T4 DNA ligase was performed at room temperature for 2 hours. 311
Inverse PCR was performed with 6 µl of ligated DNA using the oligonucleotides 6212 and 6420 (or 7195 312 and 7196 in the case of the TnFLXPhyi series) in a 50 µl reaction. The amplified fragment was analyzed 313 by Sanger sequencing (IDT) using the universal sequencing oligo 6224. 314 315
Fluorescence microscopy 316
Microscopy was performed with a Nikon eclipse 80i microscope, equipped with a Plan Apo 100X Ph 3 317 objective (NA 1.4). Cells were mounted on 1% (wt/vol) agarose pads containing S7 50 minimal medium (51) 318 on object slides. Images were acquired with a Cool snap HQ2 camera (Photometrix) and were processed 319 with Metamorph 7.7.9 software (Universal Imaging Corp.). Membranes were stained with FM4-64 (final 320 concentration, 1 nM; Molecular Probes). 321
Flow Cytometry 322
Cells were grown in LB-medium at 37° C to an OD600 of 0.7, sedimented, and resuspended in phosphate 323 buffered saline at a concentration of 5x10 6 cells/ml. Analysis and cell sorting were performed, using a 324
FACSAriaII flow cytometer (BD Biosciences) equipped with an 85 µm nozzle. Cells that were separated by 325 FACS were collected in a reaction tubes containing LB medium that was complemented with the 326 appropriate antibiotic and transferred onto fortified medium for further incubation. Table 1 
